Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C2301
http://purl.obolibrary.org/obo/NCIT_C2301
|
|---|---|
| Preferred Name | Testolactone |
| Definitions |
A progesterone derivative with antineoplastic activity. Testolactone inhibits steroid aromatase, thereby preventing the formation of estrogen from adrenal androstenedione and reducing endogenous estrogen levels. (NCI04)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A progesterone derivative with antineoplastic activity. Testolactone inhibits steroid aromatase, thereby preventing the formation of estrogen from adrenal androstenedione and reducing endogenous estrogen levels. (NCI04) |
|---|---|
| prefLabel | Testolactone
|
| label | Testolactone
|
| CHEBI_ID | CHEBI:9460
|
| PDQ_Closed_Trial_Search_ID | 42916
|
| code | C2301
|
| prefixIRI | NCIT:C2301
|
| in_subset | |
| Preferred_Name | Testolactone
|
| FDA_UNII_Code | 6J9BLA949Q
|
| Contributing_Source | FDA
|
| Chemical_Formula | C19H24O3
|
| Maps_To | Testolactone
|
| CAS_Registry | 968-93-4
|
| NSC Number | 23759
|
| NCI_Drug_Dictionary_ID | 42916
|
| Legacy Concept Name | Testolactone
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 42916
|
| Semantic_Type |
Organic Chemical
Pharmacologic Substance
Hormone
|
| UMLS_CUI | C0039600
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |